Medicare Enrolled

Dr. Misty Sinclair, MD

Neurology · Pinehurst, NC
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
1 PAGE RD, Pinehurst, NC 28374
9102956868
In practice since 2006 (20 years)
NPI: 1215993803 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sinclair from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sinclair? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sinclair

Dr. Misty Sinclair is a neurology specialist in Pinehurst, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Sinclair performed 41,579 Medicare services across 449 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sinclair received a total of $228,437 from 71 pharmaceutical and/or device companies across 912 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sinclair is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 2% volume in NC $228,437 industry payments

Medicare Practice Summary

Medicare Utilization ↗
41,579
Medicare services
Top 2% in NC for neurology
449
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,079 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
41,000 $5 $10
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
217 $60 $176
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
176 $93 $259
Bilateral facial and neck nerve muscle paralysis injection
Injection of a chemical agent to paralyze muscles in the face and neck on both sides.
148 $104 $347
Sleep study in sleep lab (age 6+)
An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older.
16 $461 $1,480
EEG, extended monitoring
A test that records electrical activity in the brain while the patient is both awake and asleep.
11 $336 $980
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
11 $108 $398
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$228,437
Total received (2018-2024)
Avg $32,634/year across 7 years
Top 3% in NC for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
71
Companies
912
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$221,319 (96.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,118 (3.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,320
2023
$1,155
2022
$8,579
2021
$15,709
2020
$45,015
2019
$89,173
2018
$67,486

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$301
PFIZER INC.
$234
Teva Pharmaceuticals USA, Inc.
$147
Lundbeck LLC
$105
Novartis Pharmaceuticals Corporation
$71
Biogen, Inc.
$68
UCB, Inc.
$64
HARMONY BIOSCIENCES LLC
$51
Lilly USA, LLC
$47
ACADIA Pharmaceuticals Inc
$34
EMD Serono, Inc.
$33
JAZZ PHARMACEUTICALS INC.
$32
Otsuka America Pharmaceutical, Inc.
$31
BANNER LIFE SCIENCES, LLC
$26
Sumitomo Pharma America, Inc.
$21
Neurocrine Biosciences, Inc.
$20
Neurelis, Inc.
$19
Celgene Corporation
$15
Top 3 companies account for 51.7% of 2024 payments
All-time payments by company (2018-2024) ›
Teva Pharmaceuticals USA, Inc.
$87,296
GENZYME CORPORATION
$54,385
Allergan Inc.
$43,117
Supernus Pharmaceuticals, Inc.
$21,433
Allergan, Inc.
$13,434
AbbVie Inc.
$2,475
Novartis Pharmaceuticals Corporation
$583
Biogen, Inc.
$474
ABBVIE INC.
$466
PFIZER INC.
$430
UCB, Inc.
$326
Lundbeck LLC
$279
Amgen Inc.
$267
Lilly USA, LLC
$255
Biohaven Pharmaceuticals, Inc.
$190
EMD Serono, Inc.
$180
Biohaven Pharmaceutical Holding Company Ltd.
$166
ACADIA Pharmaceuticals Inc
$159
Mitsubishi Tanabe Pharma America, Inc.
$138
Sunovion Pharmaceuticals Inc.
$127
US WorldMeds, LLC
$126
Acorda Therapeutics, Inc
$117
Upsher-Smith Laboratories LLC
$113
Neurocrine Biosciences, Inc.
$96
ARBOR PHARMACEUTICALS, INC.
$96
Bausch Health US, LLC
$95
UPSHER-SMITH LABORATORIES LLC
$93
Alexion Pharmaceuticals, Inc.
$89
Adamas Pharmaceuticals, Inc.
$89
ARGENX US, INC.
$80
Avanir Pharmaceuticals, Inc.
$72
Takeda Pharmaceuticals U.S.A., Inc.
$62
JAZZ PHARMACEUTICALS INC.
$56
InSightec,Inc
$56
Bayer HealthCare Pharmaceuticals Inc.
$55
HARMONY BIOSCIENCES LLC
$51
BANNER LIFE SCIENCES, LLC
$50
Amneal Pharmaceuticals LLC
$50
IMPEL PHARMACEUTICALS INC.
$49
CSL Behring
$46
Celgene Corporation
$44
Genentech USA, Inc.
$41
Eisai Inc.
$36
Abbott Laboratories
$36
Impax Laboratories, Inc.
$35
Assertio Therapeutics, Inc.
$34
Greenwich Biosciences, Inc.
$33
Otsuka America Pharmaceutical, Inc.
$31
GE HEALTHCARE
$31
AQUESTIVE THERAPEUTICS, INC.
$31
EISAI INC.
$30
Promius Pharma LLC
$24
Egalet US Inc
$23
Inspire Medical Systems, Inc.
$22
Sumitomo Pharma America, Inc.
$21
Aprecia Pharmaceuticals, LLC
$21
Neurelis, Inc.
$19
Mylan Pharmaceuticals Inc.
$19
Mallinckrodt LLC
$18
Daiichi Sankyo Inc.
$17
Nevro Corp.
$17
Jazz Pharmaceuticals Inc.
$16
Corium, LLC
$16
Purdue Pharma L.P.
$14
Mallinckrodt Enterprises LLC
$14
Collegium Pharmaceutical, Inc.
$13
Janssen Pharmaceuticals, Inc
$13
Galderma Laboratories, L.P.
$13
Kyowa Kirin, Inc.
$12
BioDelivery Sciences International, Inc.
$11
Grifols USA, LLC
$11
Top 3 companies account for 80.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BELBUCA · BOTOX · BOTOX - NEUROLOGY · BOTOX THERAPEUTIC · Betaseron · Briviact · COMIRNATY · COPAXONE · Cambia · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · Epidiolex · Exablate · Fintepla · Fycompa · GILENYA · GOCOVRI · Gamunex-C · Glatiramer Acetate · Gralise · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · INSPIRE · Infinity DBS Pulse Generators · KESIMPTA · LEMTRADA · LINZESS · LYRICA · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · Morphabond ER · NAMZARIC · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OXTELLAR XR · Omnia · Ongentys · PAXLOVID · POMPE - DISEASE · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · REXULTI · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SPRIX · SUNOSI · SYMPAZAN · SYMPROIC · Spritam · TECFIDERA · TOSYMRA · TROKENDI XR · TYSABRI · Tosymra Sumatriptan Nasal Spray · Trintellix · Trudhesa · UBRELVY · VALTOCO · VUMERITY · VYEPTI · VYVANSE · VYVGART · VYVGART HYTRULO · Vimpat · Vyvanse · WAKIX · XARELTO · XYWAV · Xadago · ZEMBRACE SYMTOUCH · ZEPOSIA · ZIPSOR · Zembrace · Zembrace SymTouch Sumatriptan Injection
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (97%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for neurology in NC.

Looking for a neurology specialist in Pinehurst?
Compare neurologists in the Pinehurst area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
16
Per 100K population
15.6
County median income
$82,837
Nearest hospital
FIRSTHEALTH MOORE REGIONAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Sinclair is a mixed practice specialist, with above-average Medicare volume (top 2% in NC), with speaking/promotional industry engagement in the top 3% of NC peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Sinclair experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Sinclair performed 41,000 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sinclair receive payments from pharmaceutical companies?
Yes. Dr. Sinclair received a total of $228,437 from 71 companies across 912 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sinclair's costs compare to other neurologists in Pinehurst?
Dr. Sinclair's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sinclair) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →